The two-signal model states that activation of naive T cells requires a signal 1 stimulus through the TCR and a co-stimulatory signal 2. By contrast, signal 1 alone is sufficient for pre-activated T cells. Recently, however, it has been shown that under certain conditions T cells can bypass the requirement for co-stimulation. For example, CD28-deficient mice, when immunized with lymphocytic choriomeningitis virus, mount a vigorous cytotoxic T lymphocyte response and clear the virus. As a continuous effort to unravel the mechanisms of T cell activation, we previously reported activation of hybridoma T cells by recombinant single-chain MHC molecules in the absence of antigen-presenting cells. In such reconstitution experiments, since the signals delivered to the T cells are well controlled, the contribution of any known or unknown signals can be ruled out. In the present study, we analyzed the requirements for activation of naive T cells by using splenocytes from TCR transgenic mice as a source of responding cells. We observed that naive CD8 ϩ T cells are fully activated by signal 1 alone, but that co-stimulation lowers their activation threshold. Previously activated T cells are fully responsive, even when the first stimulation was performed in the absence of co-stimulation. They display a low activation threshold and are insensitive to co-stimulation. The physiological relevance of this finding and its consequences for immunotherapy as well as for our understanding of self-tolerance are discussed.
Introduction
Co-stimulation is believed to be critical for optimal induction of T cell responses (1) (2) (3) . Current models suggest that activation of naive T cells is determined by the combination of two signals. One signal functions through the antigenspecific TCR complex (signal 1). The second is dependent upon the interaction between specialized molecules expressed at the surface of the T cell and their counterparts on the antigen-presenting cell (APC) (signal 2). This additional requirement for T cell activation is thought to be important in establishing and maintaining peripheral self-tolerance by preventing naive T cells from responding to a self antigen that was not presented in the thymus or that had somehow escaped negative selection (4) . When resting CD4 ϩ T cells are stimulated in the absence of signal 2, they usually become refractory to further stimulation, a state known as anergy (3) . Anergy of CD8 ϩ T cells is a more complex phenomenon (5) .
In order to reassess the role of co-stimulation in naive CD8 ϩ T cell activation, we developed an in vitro system in which all signals delivered to the T cell are purified molecules: signal 1 is provided by recombinant single-chain MHC molecules loaded with synthetic peptide (SC-Kd/HA complexes) (30, 31) and signal 2 is provided by an agonistic anti-CD28 mAb. These molecules are immobilized onto plastic plates and no additional APC are required. We previously used this approach to analyze the requirements for the activation of hybridoma T cells (32) . As a source of naive T cells, we used purified CD8 ϩ splenocytes from the clone-4 transgenic mouse (33) . This mouse is transgenic for a K d -restricted TCR specific for a peptide (HA) derived from the hemagglutinin protein of the influenza virus.
We found that naive CD8 ϩ T cells can be fully activated by MHC-peptide complexes alone, as judged by blast transformation, expression of activation markers, proliferation, secretion of various cytokines and induction of cytotoxic activity. In the presence of co-stimulation, however, the activation threshold was reduced Ͼ20 times. When previously activated T cells were analyzed, no effect of co-stimulation was observed. Interestingly, the activation threshold was comparable in naive T cells in the presence of co-stimulation and in pre-activated T cells with or without co-stimulation.
Methods

Mice
Clone-4 TCR-Tg mice (33) in the BALB/c background were bred and maintained at the Pasteur Institute under pathogenfree conditions in accordance with institutional guidelines. For experiments that used clone-4 TCR-Tg mice on a H-2 b background (clone-4 TCR/B6-Tg mice), the Tg mice were backcrossed for seven generations with C57BL/6 mice and the presence of both the transgene and H-2 b haplotype was confirmed by FACS analysis.
Peptides
The HA (IYSTVASSL) and CW3 (RYLKNGKETL) peptides have been previously described (34, 35) , and were obtained from Neosystem (Strasbourg, France).
Cell line and mAb
The P815 cell line (H-2 d , TIB64; ATCC, Rockville, MD) was maintained in RPMI 1640 medium supplemented with 10% heat-inactivated FCS. SF1-1.1.1 mAb (HB159) specific for the α3 domain of H-2K d was obtained from ATCC. mAb used for FACS analyses were purchased from either PharMingen (San Diego, CA) (anti-CD3, anti-CD69, anti-B220 and anti-CD62L), Caltag (San Francisco, CA) (anti-CD4, anti-CD8, anti-CD25, anti-CD44 and anti-V β 8.1/8.2) or Serotec (Oxford, UK) (antimacrophage F4/80). S4B6 anti-IL-2 antibody was a gift from DNAX (Palo Alto, CA). The CTLA-4-Ig fusion protein was generously provided by Dr P. Linsley (Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA). mAb anti-CD28 was purchased from PharMingen.
Immobilization of SC-Kd and anti-CD28 mAb
Single-chain K d (SC-Kd) was prepared and loaded with either HA or CW3 peptide as previously described (32) . Flatbottomed plates (96-well) (TPP, Trasadingen, Switzerland) were incubated for 2 h at 37°C with varying concentrations of SF1-1.1.1 mAb, washed twice with PBS, blocked by incubation with 50% FCS and washed twice more with PBS. SC-Kd/HA or SC-Kd/CW3 (at twice the stoechiometric amount of SF1-1.1.1) was added for 2 h at 37°C and the plates were finally washed twice more before use. For experiments with anti-CD28 mAb, plates were incubated with SF1-1.1.1-dimerized SC-Kd/HA containing 5 µg/ml of anti-CD28 antibodies. Plates were then washed and blocked as described above.
Purification of CD8 ϩ splenocytes CD8 ϩ T cells were purified by positive selection from total splenocytes of Tg mice by indirect staining and magnetic separation. Briefly, 10 8 splenocytes were depleted of red cells and treated with purified anti-CD8 mAb (PharMingen) for 45 min at 4°C and washed. Magnetic microbeads (Myltenyi Biotec, Auburn, CA) coupled to goat anti-rat IgG were added for 15 min at 4°C. The splenocytes were washed, and separated by chromatography on a column attached to a magnet. The purified population consisted of Ͼ98.5% CD8 ϩ splenocytes, as revealed by FACS analysis.
T cell proliferation assay CD8 ϩ T cells purified from the spleen of the clone-4 Tg mice (10 5 cells/well, unless specified otherwise) were added to the SC-Kd/HA-or SC-Kd/CW3-coated wells. After 24 h of culture, [ 3 H]thymidine was added and incorporation of radioactivity was measured after labeling for 16 h. In some experiments, IL-2 (human recombinant IL-2; Immugenex, Los Angeles, CA) was added at the beginning of the stimulation. Phorbol myristyl acetate (PMA) and Ca ϩ ionophore (A23187) were from Sigma (St Louis, MO). For re-stimulation experiments, 10 5 purified CD8 ϩ T cells per well were added to wells coated with SCKd/HA with or without anti-CD28 mAb and incubated for 72 h. The cells were then allowed 6 days of rest in the absence of SC-Kd/HA and in the presence of 15 ng/ml of IL-2 before being re-stimulated by incubating them for 24 h in fresh SC-Kd/HA-coated wells with and without anti-CD28 mAb. Incorporation of [ 3 H]thymidine was measured as above.
Cytotoxic T lymphocyte (CTL) induction
Purified CD8 ϩ splenocytes from clone-4 transgenic mice (3ϫ10 6 cells) were added to 96-well plates coated with 2 µg/ ml of SC-Kd/HA and incubated at 37°C for 3 days in the presence of CW3 peptide competitor at 50 µg/ml and in the absence of exogenous IL-2. The cells were then pooled and viable cells were numerated by Trypan blue exclusion. The cells were assayed for cytotoxic activity on 51 Cr-labeled P815 target cells pulsed with either HA or CW3 peptide as previously described (36) .
Cytokine assays
Purified CD8 ϩ splenocytes (10 5 /well) were added to 96-well plates coated with either 2 µg/ml of SC-Kd/HA in the presence of CW3 peptide competitor (50 µg/ml) or 20 µg/ml of SC-Kd/ CW3. In both cases exogenous IL-2 was omitted. Culture supernatants were collected at different times after stimulation. TNF production was measured by bioassay using WEHI-164 indicator cell line as previously described (37) . IFN-γ, IL-2, IL-3, IL-4, IL-6, IL-10 and granulocyte macrophage colony stimulating factor (GM-CSF) production were measured in culture supernatants by ELISA assays (38) .
Cytometry analysis
Purified CD8 ϩ splenocytes (10 5 /well) were stained with various conjugated antibodies for 30 min on ice in FACS buffer (2% FCS, 0.01% Na azide in PBS). Gates to exclude non-viable cells were determined using propidium iodide (Sigma). Data on viable cells were acquired and analyzed on a FACScan using CellQuest software (Becton Dickinson, San Jose, CA).
Cell survival experiments
Purified CD8 ϩ splenocytes (10 5 /well) were added to 96-well plates coated with either 2 µg/ml of SC-Kd/HA in the presence of CW3 peptide competitor (50 µg/ml) or 20 µg/ml of SC-Kd/ CW3, and with or without immobilized anti-CD28 mAb. Cells were collected 3 days after stimulation and the numbers of live and dead cells were determined by Trypan blue exclusion. Concanavalin A (Con A) was purchased from Pharmacia (Uppsala, Sweden).
Results
A proliferative response is elicited by immobilized SC-Kd/HA complexes alone SC-Kd molecules were loaded with the HA peptide and immobilized on plastic plates with the K d -specific antibody SF1-1.1.1. This antibody, which recognizes an epitope in the α3 domain, had been previously used to generate dimers of SC-Kd with a topology compatible with T cell activation (32) . CD8 ϩ T cells were purified from total splenocytes of clone-4 Tg mice using a CD8-specific antibody and species-specific second antibody coupled to magnetic beads as described in the Methods section. As shown in Fig. 1 , this procedure reproducibly yielded preparations containing Ͼ98.5% of CD8 ϩ T cells.
In response to the immobilized SC-Kd/HA complexes, purified clone-4 CD8 ϩ splenocytes proliferated in a dose-dependent manner (Fig. 2) . Interestingly, addition of exogenous IL-2 was not necessary and had no effect on proliferation. In response to a PMA/calcium ionophore mixture, the purified CD8 ϩ splenocytes proliferated to a level comparable to that observed with the SC-Kd/HA complexes. The concentration of SC-Kd/HA required for half maximal proliferation was between 0.5 and 0.6 µg/ml, irrespective of the presence or absence of exogenous IL-2. Proliferation was peptide-specific as SC-Kd loaded with the irrelevant peptide CW3 failed to elicit any T cell proliferation (Fig. 2) . These data indicate that immobilized class I MHC molecules are able to induce the proliferation of purified naive CD8 ϩ splenocytes in a peptide-specific manner. Similar results were obtained with equivalent concentrations of soluble dimerized SC-Kd/ HA (data not shown), indicating that immobilization on plastic does not play a role in the CD8 ϩ T cell specific response.
Immobilized SC-Kd/HA molecules alone are responsible for the CD8 ϩ T cell activation
We first needed to establish that our preparations of clone-4 CD8 ϩ splenocytes maintained a naive phenotype during purification. For this purpose, we analyzed the distribution of cell sizes and the expression of CD69, CD25, CD62L and CD44 at the surface of the purified CD8 ϩ T cells by flow cytometry. As shown in Fig. 3 (day 0), Ͼ85% of the purified T cells were small, CD69 -, CD62L ϩ , CD25 -and CD44 low . Three-parameter analyses confirmed this estimate. These figures were indistinguishable from those of non-purified clone-4 splenocytes, which indicated that the purification procedure did not alter the activation level of the T cells.
To further substantiate this point, we also 'negatively' purified clone-4 CD8 ϩ T cells using antibodies against B (B220), CD4 ϩ (L3T4) and macrophage (F4/80) cells to deplete those cells from the transgenic splenocytes, and found that cells purified in this way responded to immobilized SC-Kd/HA in a fashion similar to that for the 'positively' selected cells (Fig. 4D) . However, since negative selection gave lower yields and lower purity preparations, we chose the 'positive' purification for all subsequent experiments.
To rule out the possibility that minor contamination by APC might have influenced the results, we examined the effect of decreasing cell density while keeping the concentration of SC-Kd/HA constant. SC-Kd/HA complexes (20 µg/ml) were immobilized and serial dilutions of purified clone-4 CD8 ϩ splenocytes from 1.5ϫ10 3 to 10 5 cells/ml were added. As shown in Fig. 5 , a linear relationship between the number of seeded T cells and the measured proliferation was observed over the whole range of concentrations, suggesting that no cell-cell interaction was required for T cells to proliferate. Addition of neutralizing anti-IL-2 mAb did not affect the linearity of T cell response (Fig. 5) . We also measured the plating efficiency of CD8 ϩ naive T cells on plates coated with SC-Kd/HA in the absence of exogenous IL-2. Plating efficiency was 1:13 Ϯ 2 ( Fig. 6 ). It was not affected by addition of exogenous IL-2 (data not shown). Together, these results exclude any role in T cell activation of either purification procedure, cell-cell interaction or rare contaminant CD8 -cells.
Finally, we demonstrated that SC-Kd/HA complexes were indeed the activating stimulus received by the naive CD8 ϩ splenocytes by performing three additional controls. We verified that purified clone-4 CD8 ϩ splenocytes did not proliferate when 40 ng/ml of peptide were added, which corresponded to the total amount of the peptide contained in~2 µg/ml of SC-Kd/HA complexes, at which concentration proliferation is maximum (Fig. 4A ). We also tested the effect of an excess of irrelevant, K d -binding peptide on purified clone-4 CD8 ϩ splenocyte proliferation induced by SC-Kd/HA. As shown in Fig. 4 (A), a 1250-fold excess of the CW3 peptide had no effect on the proliferation of purified clone-4 CD8 ϩ splenocytes induced by immobilized SC-Kd/HA. By contrast, adding CW3 abolished the proliferation of non-purified splenocytes induced by the HA peptide alone, showing that this CW3 concentration was sufficient to block the available K d molecules on the APC. All subsequent experiments were therefore performed in the presence of 50 µg/ml of the CW3 peptide. Finally, we tested the response of clone-4 CD8 ϩ splenocytes in an H-2 b background, in order to rule out the putative presentation of any HA molecules by contaminating APC. For that purpose, we crossed the clone-4 Tg mouse on an H-2 b haplotype, as described in Methods. Interestingly, although the clone-4 Tg TCR is K d -restricted, some HA-reactive T cells were positively selected on the H-2 b background. CD8 ϩ splenocytes from these mice were purified and assayed for proliferation induced by immobilized SC-Kd/HA as described above. As shown in Fig. 4(D) , these H-2 b CD8 ϩ Tg splenocytes proliferated in response to immobilized SC-Kd/HA, although the level of proliferation was somewhat lower than that obtained with cells purified from the H-2 d clone-4 Tg mice. This lower proliferation reflected the fact that only a fraction of the cells responded to the stimulus, as up-regulation of CD69 was only detected on 10% of the H-2 b CD8 ϩ splenocytes at 24 h (data not shown). Proliferation of H-2 b clone-4 Tg splenocytes was peptide specific as SC-Kd/CW3 did not induce proliferation (Fig. 4D) .
Taken together these results indicate that the observed proliferation was not due to the release of HA peptide from the immobilized SC-Kd/HA complexes and its binding to K d molecules expressed by cells. Rather, SC-Kd/HA complexes were indeed the activating stimulus received by the clone-4 CD8 ϩ splenocytes.
SC-Kd/HA-induced proliferation does not require CD28/B7 interaction CD8 ϩ T cells used in the proliferation experiments were highly purified. In order to exclude that a small number of contaminating APC or T cells expressing B7 might provide co-stimulation, we performed the proliferation assay in the presence of 10 µg/ml of CTLA-4-Ig fusion protein. Control experiments indicated that, as previously reported (9), this concentration was sufficient to fully inhibit a primary allogeneic mixed lymphocyte reaction of C57BL/6 splenocytes in response to irradiated DBA/2 (Fig. 4B) . As shown in Fig. 4(C) , and as expected if the only stimulus provided to the T cells is SC-Kd/HA complexes, CTLA-4-Ig had no effect on clone-4 CD8 ϩ splenocyte proliferation.
Clone-4 CD8 ϩ splenocytes stimulated by immobilized SCKd/HA complexes exhibit an activated phenotype
In order to determine whether the proliferation of clone-4 CD8 ϩ splenocytes stimulated by immobilized SC-Kd/HA complexes was associated with an activated phenotype, we analyzed the expression of several activation markers by flow cytometry (Fig. 3) . As mentioned above, purified clone-4 CD8 ϩ splenocytes were CD69 -, CD25 -, CD44 low , CD62L high and of small size, indicating a naive phenotype (Fig. 3, day  0) . After the cells were stimulated for 3 days by immobilized SC-Kd/HA complexes in the absence of added IL-2, blast transformation was observed in 90% of the cells. CD69 and CD25 expression was detected on 94 and 93% of the cells respectively. CD44 expression was up-regulated from dull to bright and CD62L expression decreased on~20% of the cells (Fig. 3, day 3) . In fact, after only 16 h of stimulation 90% of the activated cells exhibited up-regulation of CD69 (data not shown). Conversely, kinetics experiments indicated that 8 days were required to observe CD62L down-modulation in Ͼ80% of the cells. These results demonstrated that (i) after purification, clone-4 CD8 ϩ splenocytes display a naive phenotype and (ii) immobilized SC-Kd/HA complexes stimulate the vast majority of the cells to acquire a fully activated phenotype.
Clone-4 CD8 ϩ splenocytes stimulated by immobilized SCKd/HA complexes secrete cytokines We next determined whether proliferation and activation of clone-4 CD8 ϩ splenocytes were associated with differentiation into effectors. We assayed the production of various cytokines after stimulation with immobilized SC-Kd/HA complexes, without addition of exogenous IL-2 in the presence of an excess of CW3 peptide ( Table 1) . Production of both IFN-γ and IL-3 was detected after 24 h and increased at day 3 ( Table 1 , rows 2 and 3), while that of TNF and GM-CSF was more precocious, and also increased with time (Table 1 , rows 1 and 4) Cytokine production was peptide specific as no cytokine was detected when cells were incubated in the presence of SC-Kd loaded with an irrelevant peptide ( Table 1 , SC-Kd/CW3). Naive CD8 ϩ splenocytes (immediately after purification) did not produce detectable amounts of those cytokines (Table 1 , day 0). We were unable to detect any IL-2, IL-4, IL-6 and IL-10 production in the supernatants of cells activated by SC-Kd/HA (data not shown). In order to further characterize clone-4 CD8 ϩ T cell blasts obtained after stimulation by immobilized SC-Kd/HA, we assayed cytotoxic activity. Purified clone-4 CD8 ϩ splenocytes were activated for 3 days in the absence of exogenous IL-2 and in the presence of an excess of CW3 peptide. Activated cells were incubated at different effector to target cell ratios for 6 h with 51 Cr-labeled P815 cells pulsed with HA. As shown in Fig. 7 , while no cytotoxic activity was detected immediately after purification (Fig. 7B ), significant lysis was observed with clone-4 CD8 ϩ T cells activated for 3 days (Fig. 7A ). This lysis was peptide specific as P815 cells pulsed with irrelevant CW3 peptide were not lysed (Fig. 7, open symbols) . Moreover, the cytotoxic activity induced by SC-Kd/HA was comparable to that of naive CD8 ϩ T cells activated by professional APC loaded with the HA peptide (Fig. 7C ).
Co-stimulation through CD28 lowers the activation threshold
In order to assess the effect of co-stimulation on the activation of purified CD8 ϩ splenocytes, we added to the SC-Kd/HA stimulus a fixed concentration of anti-CD28 mAb that mimics CD28/B7 interactions. In response to increasing concentrations of immobilized SC-Kd/HA, purified clone-4 CD8 ϩ splenocytes proliferated in a dose-dependent manner in the absence as well as in the presence of anti-CD28 antibodies (Fig. 8) . However, the SC-Kd/HA concentration necessary to reach half maximal T cell proliferation was at least 20 times lower in the presence of anti-CD28 mAb than when it was absent (0.008-0.01 versus 0.2-0.5 µg/ml). Interestingly, the effect of the anti-CD28 mAb decreased with the increasing SC-Kd/HA concentration such that anti-CD28 mAb did not affect T cell proliferation at high concentrations of immobilized SC-Kd/HA. We also analyzed the effect of anti-CD28 mAb on T cell survival and apoptosis. As shown in Table 2 , a large increase in the numbers of viable and apoptotic cells was observed upon activation with SC-Kd/HA. A similar increase was observed after addition of anti-CD28 mAb.
TCR down-modulation during activation is unaffected by costimulation
In order to shed some light on the possible mechanisms by which CD28 signaling lowers the activation threshold of naive CD8 ϩ T cells, we performed TCR occupancy analyses. We compared TCR expression on purified CD8 ϩ splenocytes Fig. 7 . CD8 ϩ splenocytes activated by SC-Kd/HA elicit a specific cytotoxic activity. (A) Purified CD8 ϩ splenocytes (3ϫ10 6 ) were incubated in plates coated with 2 µg/ml of SC-Kd/HA for 3 days at 37°C in the absence of recombinant human IL-2 and in the presence of 50 µg/ml CW3. Cytolytic activity was tested on P815 target cells pulsed with either 1 µM HA (closed symbols) or CW3 (open symbols). (B) Purified CD8 ϩ splenocytes (3ϫ10 6 ) were used immediately after purification. (C) Purified CD8 ϩ splenocytes (3ϫ10 6 ) were incubated for 3 days in the presence of irradiated autologous splenocytes loaded with HA (10 -6 M). Purified CD8 ϩ splenocytes (10 5 /well) were incubated for 3 days in the absence or the presence of different stimuli. CW3 competitor peptide (50 µg/ml) was added in each well.
a Concentration of immobilized SC-Kd/HA or SC-Kd/CW3 complexes was 20 µg/ml.
b Concentration of immobilized anti-CD28 mAb was 2.5 µg/ml. c Con A was used at 5 µg/ml. cells that had been activated for 5 h with increasing concentrations of SC-Kd/HA in the presence or absence of anti-CD28 mAb. As shown in Fig. 9 and as previously reported (39), a dose-dependent, peptide-specific down-modulation of the TCR was observed, that was not altered by addition of anti-CD28 mAb.
Co-stimulation through CD28 has no effect on the response of pre-activated CD8 ϩ T cells
Activation of CD4 ϩ T cells in the absence of co-stimulation results in T cell anergy (3). We therefore tested the capacity of CD8 ϩ T cells that had been previously activated with SCKd/HA to respond in a secondary stimulation. Naive CD8 ϩ T cells were first stimulated with SC-Kd/HA in the presence or absence of anti-CD28 mAb for 3 days. After re-isolation and culture for 6 days in the absence of stimulus, T cells were restimulated with immobilized SC-Kd/HA in the presence and absence of anti-CD28 and proliferation assayed. Proliferation was very similar regardless of the presence or absence of anti-CD28 mAb during initial stimulation and re-stimulation (Fig. 10) . Furthermore, the SC-Kd/HA concentration that was necessary for half maximal T cell proliferation was between 0.008 and 0.01 µg/ml in all cases, and was therefore in the same range as we observed upon primary activation of the CD8 ϩ splenocytes in the presence of co-stimulation. We concluded from these results that co-stimulation had no effect on the response of pre-activated T cells to SC-Kd/HA and that the low activation threshold of the CD8 ϩ T cells could be reached both by re-stimulation of preactivated T cells or primary stimulation in the presence of co-stimulation.
Discussion
In the present study, we have analyzed the role of costimulation in the activation of naive CD8 ϩ T cells. We have demonstrated that naive CD8 ϩ T cells can be fully activated through signal 1 alone, i.e. a single-chain MHC class I molecule loaded with a relevant peptide and immobilized onto plastic. T cell activation was not dependent upon the addition of exogenous IL-2. Using recombinant MHC molecules and TCR Tg T cells allowed us to examine naive CD8 ϩ T cell activation in an environment devoid of any other cells.
Taking advantage of this cell-free system we were able to show that co-stimulation provided by an anti-CD28 mAb lowers the activation threshold of these cells. By contrast, previously activated CD8 ϩ T cells were insensitive to costimulation and already displayed a low activation threshold comparable to that of naive cells activated in the presence of co-stimulation. The naive T cells used in this study were purified from total splenocytes harvested from mice Tg for the clone-4 TCR, which is K d -restricted and specific for a viral peptide derived from influenza HA. We assumed that the mice were naive with respect to the HA peptide, since influenza HA is not expressed as a self antigen. Nevertheless, due to T cell repertoire degeneracy, some self peptide could react with the Tg TCR, as has been described for a HSV peptide (40) . Such crossreaction could somehow induce a priming of the T cells. Likewise, our purification procedure which uses an anti-CD8 mAb could be suspected of somehow presensitizing the T cells. Both possibilities can be ruled out since the phenotype of the purified cells before activation was clearly naive, based on cell size, expression of activation molecules and absence of effector functions (Figs 3 and 7, and Table 1 ). Second, 'negatively' purified CD8 ϩ T cells were similarly stimulated by SC-Kd/HA alone (Fig. 4D) .
Purified recombinant MHC-peptide complexes were used to activate the naive CD8 ϩ T cells. Nevertheless, it could be argued that some of the peptide could dissociate from the complex and re-bind to K d molecules expressed by T cells or by potentially contaminating APC. This scenario seems unlikely, however. First, CD8 ϩ T cells were highly purified (Fig. 1) . Second, the HA peptide alone at concentration equal to that of the peptide within the SC-Kd/HA complexes did not activate the purified naive CD8 ϩ T cells (Fig. 4A) . Third, while an excess of irrelevant peptide that binds to K d blocked HAinduced proliferation of unpurified splenocytes, it had no effect on SC-Kd/HA-induced proliferation or differentiation of purified CD8 ϩ T cells (Fig. 4A) . Fourth, when the clone-4 TCR Tg was crossed onto a H-2 b background, in which T cells and potentially contaminating APC would be of H-2 b haplotype and incapable of binding the HA peptide (SC, unpublished observation), purified CD8 ϩ splenocytes did proliferate in response to SC-Kd/HA (Fig. 4D ). Importantly this proliferation was peptide specific and was therefore not an allogeneic reaction.
We routinely obtained purified preparations containing Ͼ98.5% pure CD8 ϩ T cells, but could not reproducibly achieve a higher level of purity. One could argue therefore that our purified CD8 ϩ splenocytes may contain a small fraction of professional APC that might be responsible for the bypass of co-stimulation reported in the present study. Note that these potential APC would have to deliver a co-stimulatory signal in trans since, as already demonstrated, HA peptide dissociating from SC-Kd/HA complexes cannot account for the observed proliferation. Several observations allowed us to rule out this interpretation. First, in experiments where the CD28/B7 interaction was blocked using the CTLA-4-Ig fusion protein, proliferation and differentiation of the purified CD8 ϩ T cells into effector was not altered (Fig. 4B and C, and data not shown). Second, we observed a linear relationship between T cell density and thymidine incorporation when the cells were diluted over a 100-fold range, as expected if the only signal required was SC-Kd/HA (Fig. 5 ). This linearity should not be observed if cell-cell collaboration was necessary in addition to SC-Kd/HA. Taken together, these arguments militate against any interpretation in which either contaminant APC or free HA peptide are responsible for activation in the absence of co-stimulation. Similarly the ligation of putative unknown co-stimulatory molecules on APC cannot explain our observations [in contrast to experiments in which a cellular stimulus was used (41) (42) (43) ]. Recently, Goldstein et al. reported that allospecific naive T cells proliferated in response to purified H-2L d MHC class I molecules (44) . Thus both studies demonstrate that full activation of naive CD8 ϩ T cells can take place in the absence of co-stimulation. However, as postulated in the strength of signal 1 model (10), high doses of signal 1 were required to observe activation of naive T cells in the absence of co-stimulation.
The presence of anti-CD28 mAb during the primary activation of CD8 ϩ T cells shifted the response curve toward lower doses of signal 1. Importantly, at high doses of SC-Kd/HA, co-stimulation did not increase the T cell response. Indeed, co-stimulation only affected the activation threshold. In these experiments, co-stimulation did not interfere with TCR down-modulation. TCR down-modulation has been used as a measure of the number of triggered TCR, i.e. of the amount of signal 1 delivered to the T cell (45) . Therefore, our results indicate that CD28 does not increase the amount of signal 1 delivered to the T cells but lowers the number of TCR that need to be triggered in order to induce T cell proliferation. This observation confirms and extends a recent study by Viola et al. (6) on CD4 ϩ T cell clones. Our experimental system could be tested with other co-stimulatory molecules to determine whether this concept applies to all co-stimulation pathways. Pre-activated CD8 ϩ T cells could be reactivated and no difference in secondary response was found, whether the cells had been pre-activated in the presence or absence of co-stimulation. Moreover, re-stimulation curves in the presence or absence of co-stimulation were indistinguishable. Therefore, the effect of co-stimulation was only observed during the primary stimulation.
It is interesting to note that when clone 4 TCR Tg mice were crossed with mice expressing the influenza virus HA on β cells (Ins-HA), double Tg mice developed spontaneous diabetes immediately after birth and died within 10 days (33) . Pancreatic β cells do not express B7 (46, 47) and therefore are not likely to provide co-stimulatory signals. Although Morgan et al. (33) could not exclude unknown co-stimulatory pathways or antigen reprocessing by professional APC residing in the islets, their finding strongly suggests that naive CD8 ϩ T cell activation in the absence of co-stimulation can also be observed in vivo. In a similar experimental system, however, using a different TCR recognizing a lymphocytic choriomeningitis virus (LCMV)-derived peptide, no diabetes was observed unless B7-1 was co-expressed by the β cells (47) . To explain this discrepancy, and in relation to the present study, we propose that the requirement for co-stimulation depends on the TCR used and the density of presentation of the cognate peptide. The availability of antibodies capable of detecting specific MHC-peptide complexes should allow a precise quantification of the HA and LCMV-derived peptides presented on β cells (48) . If some T cells can be fully activated in the absence of co-stimulation by high doses of MHC-peptide, how is selftolerance maintained? T cells expressing low-affinity TCR or recognizing poorly presented antigens are more likely to escape negative selection in the thymus. Activation of such T cells in the periphery must therefore be more tightly controlled in order to limit auto-immunity and may require co-stimulation. On the contrary, a peptide that is recognized with high affinity by a particular T cell in the periphery is less likely to be self-derived. In such a case, the T cell is likely to have been negatively selected in the thymus, thus less tight conditions may be required to activate such a T cell and bypass of co-stimulation would be possible.
Pre-activated CD8 ϩ T cells display a low threshold of activation and are insensitive to co-stimulation. This observation makes sense particularly if one considers that the main function of CD8 ϩ T cells is to eradicate intracellular pathogens. In the case of viruses, for example, while the induction of a primary response should be well controlled to prevent immuno-pathological disorders, later in the infection, when most of the virus has been cleaned up, it is important to eliminate any cell in which the virus may have found refuge and hidden, with no consideration whether this cell is a professional APC or not. T cells with low activation threshold and capable of bypassing co-stimulation will be more efficient to terminate a viral infection.
In conclusion, in this study we have demonstrated that naive CD8 ϩ T cells can be fully activated in the absence of co-stimulation at high doses of antigen but that they require co-stimulation at lower doses. Upon re-stimulation, the co-stimulation is no longer effective. Design of future peptidebased vaccines should take into account both differential co-stimulation needs for CD4 ϩ and CD8 ϩ cells, and antigenspecific co-stimulation requirements. A better understanding of the precise requirements for naive T cell activation is of crucial importance for the development of new therapeutic approaches aiming at specifically eradicating tumors and viral infections or curing auto-immune diseases.
